aTyr Pharma
ATYR · NASDAQ
$0.1733+$0.0016 (+0.93%)TodayMarket closed ·
Prev close $0.1717
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 18.5% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.1239 | -$0.11 | +11.2% |
| Q1 FY26 | -$0.1403 | -$0.11 | +21.6% |
| Q4 FY25 | -$0.1874 | -$0.14 | +25.3% |
| Q3 FY25 | -$0.1873 | -$0.26 | −38.8% |
| Q2 FY25 | -$0.1881 | -$0.22 | −17.0% |
| Q1 FY25 | -$0.1938 | -$0.17 | +12.3% |
| Q4 FY24 | -$0.2305 | -$0.18 | +21.9% |
| Q3 FY24 | -$0.2244 | -$0.23 | −2.5% |
Earnings calls
- Special Call - aTyr Pharma, Inc.
- Special Call - aTyr Pharma, Inc.
- LIFE - Earnings call Q4 2024
- 43rd Annual J.P. Morgan Healthcare Conference 2025
- LIFE - Earnings call Q4 2023
- Special Call - aTyr Pharma, Inc.
- Earnings call Q4 2022
- Earnings call Q3 2022
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.